Cargando…
Symptoms after COVID-19 Infection in Individuals with Multiple Sclerosis in Poland
(1) Background: To report and analyze the presence of residual symptoms after SARS-CoV-2 infection among Polish patients with multiple sclerosis (MS) treated with different disease-modifying therapies (DMTs). (2) Methods: The study included 426 individuals with MS treated with DMTs and confirmed SAR...
Ejemplares similares
-
Analysis of Side Effects Following Vaccination Against COVID-19 Among Individuals With Multiple Sclerosis Treated With DMTs in Poland
por: Czarnowska, Agata, et al.
Publicado: (2022) -
Safety of Vaccines against SARS-CoV-2 among Polish Patients with Multiple Sclerosis Treated with Disease-Modifying Therapies
por: Czarnowska, Agata, et al.
Publicado: (2022) -
Assessment of Disability Progression Independent of Relapse and Brain MRI Activity in Patients with Multiple Sclerosis in Poland
por: Kapica-Topczewska, Katarzyna, et al.
Publicado: (2021) -
The effectiveness of interferon beta versus glatiramer acetate and natalizumab versus fingolimod in a Polish real-world population
por: Kapica-Topczewska, Katarzyna, et al.
Publicado: (2019) -
Disturbed Ratios between Essential and Toxic Trace Elements as Potential Biomarkers of Acute Ischemic Stroke
por: Mirończuk, Anna, et al.
Publicado: (2023)